Net Income (TTM) Chart

View Net Income (TTM) for ARQT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (TTM) Chart
Start Trial

Historical Net Income (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 28.52M
March 31, 2026 -2.376M
December 31, 2025 -16.14M
September 30, 2025 -44.32M
June 30, 2025 -93.27M
March 31, 2025 -129.72M
December 31, 2024 -140.04M
September 30, 2024 -195.54M
June 30, 2024 -198.76M
March 31, 2024 -217.42M
December 31, 2023 -262.14M
September 30, 2023 -267.88M
June 30, 2023 -330.82M
March 31, 2023 -327.23M
December 31, 2022 -311.46M
Date Value
September 30, 2022 -310.76M
June 30, 2022 -260.04M
March 31, 2022 -234.64M
December 31, 2021 -206.36M
September 30, 2021 -169.08M
June 30, 2021 -150.30M
March 31, 2021 -143.71M
December 31, 2020 -135.68M
September 30, 2020 -114.20M
June 30, 2020 -90.47M
March 31, 2020 -63.35M
December 31, 2019 -42.00M
September 30, 2019 -35.03M
June 30, 2019 -28.22M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 380.48M
Insmed, Inc. -875.31M
Emergent BioSolutions, Inc. -176.80M
Exelixis, Inc. 860.62M
Vertex Pharmaceuticals, Inc. 4.405B